China Pharma Holdings, Inc.
CPHI
$1.80
-$0.04-1.96%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 756.20K | 1.03M | 1.14M | 1.13M | 1.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 756.20K | 1.03M | 1.14M | 1.13M | 1.10M |
| Cost of Revenue | 815.90K | 1.11M | 1.27M | 1.29M | 1.62M |
| Gross Profit | -59.70K | -87.00K | -136.10K | -160.60K | -519.60K |
| SG&A Expenses | 528.20K | 544.20K | 593.00K | 1.03M | 478.00K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.38M | 1.53M | 1.89M | 2.33M | 2.19M |
| Operating Income | -627.70K | -501.40K | -758.60K | -1.20M | -1.09M |
| Income Before Tax | -651.50K | -528.40K | -785.60K | -1.22M | -1.12M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -651.50K | -528.40K | -785.60K | -1.22M | -1.12M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -651.50K | -528.40K | -785.60K | -1.22M | -1.12M |
| EBIT | -627.70K | -501.40K | -758.60K | -1.20M | -1.09M |
| EBITDA | -271.70K | -180.60K | -429.30K | -748.00K | -388.30K |
| EPS Basic | -0.17 | -0.16 | -0.24 | -0.53 | -0.65 |
| Normalized Basic EPS | -0.11 | -0.10 | -0.15 | -0.33 | -0.40 |
| EPS Diluted | -0.17 | -0.16 | -0.24 | -0.53 | -0.65 |
| Normalized Diluted EPS | -0.11 | -0.10 | -0.15 | -0.33 | -0.40 |
| Average Basic Shares Outstanding | 3.87M | 3.26M | 3.26M | 2.31M | 1.73M |
| Average Diluted Shares Outstanding | 3.87M | 3.26M | 3.26M | 2.31M | 1.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |